EA201290663A1 - Состав с модифицированным высвобождением и способы применения - Google Patents

Состав с модифицированным высвобождением и способы применения

Info

Publication number
EA201290663A1
EA201290663A1 EA201290663A EA201290663A EA201290663A1 EA 201290663 A1 EA201290663 A1 EA 201290663A1 EA 201290663 A EA201290663 A EA 201290663A EA 201290663 A EA201290663 A EA 201290663A EA 201290663 A1 EA201290663 A1 EA 201290663A1
Authority
EA
Eurasian Patent Office
Prior art keywords
retigabine
individual
plasma concentration
hours
approximately
Prior art date
Application number
EA201290663A
Other languages
English (en)
Russian (ru)
Inventor
Билджана Наджсомбати
Original Assignee
Вэлиант Фармасьютикалс Интернешнл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47042234&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201290663(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US12/690,889 external-priority patent/US20100323015A1/en
Priority claimed from US12/691,680 external-priority patent/US20100323016A1/en
Application filed by Вэлиант Фармасьютикалс Интернешнл filed Critical Вэлиант Фармасьютикалс Интернешнл
Publication of EA201290663A1 publication Critical patent/EA201290663A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA201290663A 2010-01-20 2011-01-18 Состав с модифицированным высвобождением и способы применения EA201290663A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/690,889 US20100323015A1 (en) 2008-07-18 2010-01-20 Modified release formulation and methods of use
US12/691,680 US20100323016A1 (en) 2008-07-18 2010-01-21 Modified release formulation and methods of use
PCT/US2011/021498 WO2011090923A1 (fr) 2010-01-21 2011-01-18 Formulation à libération modifiée et procédés d'utilisation

Publications (1)

Publication Number Publication Date
EA201290663A1 true EA201290663A1 (ru) 2013-03-29

Family

ID=47042234

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201290663A EA201290663A1 (ru) 2010-01-20 2011-01-18 Состав с модифицированным высвобождением и способы применения

Country Status (6)

Country Link
EP (1) EP2525660A4 (fr)
BR (1) BR112012018173A2 (fr)
CL (1) CL2012002014A1 (fr)
CO (1) CO6592107A2 (fr)
EA (1) EA201290663A1 (fr)
MX (1) MX2012008475A (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK13252002A3 (sk) * 2000-03-08 2003-07-01 Awd. Pharma Gmbh & Co. Kg Farmaceutické prípravky
WO2005030181A1 (fr) * 2003-09-26 2005-04-07 Alza Corporation Preparations a liberation regulee a base d'analgesiques opioides et non opioides
KR20090083479A (ko) * 2006-11-28 2009-08-03 밸리언트 파마슈티컬즈 인터내셔널 칼륨 채널 조절제로서의 1,4 디아미노 이환 레티가빈 유사체
JP2011528666A (ja) * 2008-07-18 2011-11-24 バレアント プハルマセウトイカルス インターナショナル 放出調節製剤及びその使用方法

Also Published As

Publication number Publication date
CL2012002014A1 (es) 2013-04-05
EP2525660A1 (fr) 2012-11-28
MX2012008475A (es) 2013-11-01
BR112012018173A2 (pt) 2017-08-29
CO6592107A2 (es) 2013-01-02
EP2525660A4 (fr) 2013-08-07

Similar Documents

Publication Publication Date Title
EA201170230A1 (ru) Препарат с модифицированной кинетикой высвобождения и способы его использования
AU2014340303B2 (en) Tyrosine hydroxylase inhibitors for treating intestinal hyperpermeability
EA201071035A1 (ru) Фармацевтические композиции модифицированного высвобождения, содержащие микофенолат, и способ их получения
US10517845B2 (en) Compositions and methods for treating intestinal hyperpermeability
BRPI0908942A2 (pt) Sistemas de distribuição de fármacos compreendendo fármacos fracamente básicos e ácidos orgânicos
MA32692B1 (fr) Procede de liberation d'une composition pharmaceutique a un patient qui en a besoin
TNSN08348A1 (en) Antibiotic compositions of modified release and process of production thereof
NZ619076A (en) Isoxazolines as inhibitors of fatty acid amide hydrolase
EA201500069A1 (ru) Способы уменьшения риска развития сердечно-сосудистого события у субъекта, получающего терапию статином
EA200701575A1 (ru) Формуляция леветирацетама длительного высвобождения
EA201171109A1 (ru) Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия
CA2787907A1 (fr) Formulation a liberation modifiee et procedes d'utilisation
BRPI0915383B8 (pt) composto derivado de fenilimidazol e sua composição farmacêutica.
EA201300747A1 (ru) Твердая лекарственная форма с контролируемым высвобождением и способы ее получения и применения
FR2903107B1 (fr) Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
JP2016530279A5 (fr)
ITBO20110012A1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
RU2016135952A (ru) Композиции ингибитора дофа-декарбоксилазы
AR055090A1 (es) Una presentacion farmaceutica de forma de dosificacion de liberacion modificada que comprende un inhibidor de la enzima ciclooxigenasa
BR112012023971A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BR112012017691A2 (pt) nova composição
EA201290663A1 (ru) Состав с модифицированным высвобождением и способы применения
AR065419A1 (es) Metodo para inhibir la proliferacion de celulas tumorales
RU2015128915A (ru) Составы лоразепама с замедленным высвобождением
JP2016504390A5 (fr)